Linda Maxwell

CIK: 0001822674

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

UTHR

UNITED THERAPEUTICS Corp

Director

IBRX

ImmunityBio, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

UTHR
UNITED THERAPEUTICS Corp
Jul 22, 2026
Award(A)
Restricted Stock Unit
Direct
380 shares-
UTHR
UNITED THERAPEUTICS Corp
Jul 22, 2026
Award(A)
Stock Option
Direct
1.2K shares-
IBRX
ImmunityBio, Inc.
Jun 9, 2026
Award(A)
Stock Option (right to buy)
Direct
65.6K shares-
UTHR
UNITED THERAPEUTICS Corp
Jul 24, 2025
Award(A)
Stock Options
Direct
3.7K shares-
IBRX
ImmunityBio, Inc.
Jun 18, 2025
Award(A)
Stock Option (right to buy)
Direct
162.8K shares-

		Type	Shares	Price		Ownership
Jul 22, 2026	UTHR UNITED THERAPEUTICS Corp	Award(A) Restricted Stock Unit	380	-	-	Direct
Jul 22, 2026	UTHR UNITED THERAPEUTICS Corp	Award(A) Stock Option	1,190	-	-	Direct
Jun 9, 2026	IBRX ImmunityBio, Inc.	Award(A) Stock Option (right to buy)	65,600	-	-	Direct
Jul 24, 2025	UTHR UNITED THERAPEUTICS Corp	Award(A) Stock Options	3,650	-	-	Direct
Jun 18, 2025	IBRX ImmunityBio, Inc.	Award(A) Stock Option (right to buy)	162,786	-	-	Direct

1-5 of 5 transactions

About MAXWELL LINDA

MAXWELL LINDA (SEC CIK 0001822674) files insider reports with the SEC as Director of UNITED THERAPEUTICS Corp (UTHR) and Director of ImmunityBio, Inc. (IBRX).

Signal8 holds 4 ownership filings by MAXWELL LINDA, all Form 4s, filed between Jun 20, 2025 and Jul 23, 2026. Those filings report 5 transactions, from Jun 18, 2025 to Jul 22, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on MAXWELL LINDA's filings is in SILVER SPRING, MD.

Recent filings by MAXWELL LINDA

Jul 22, 2026: Grants or awards of UTHR derivative securities (2 lines, Form 4, code A).
Jun 9, 2026: Grant or award of IBRX derivative securities (Form 4, code A).
Jul 24, 2025: Grant or award of UTHR derivative securities (Form 4, code A).
Jun 18, 2025: Grant or award of IBRX derivative securities (Form 4, code A).

Other insiders filing for UNITED THERAPEUTICS Corp (UTHR)

ROTHBLATT MARTINE A, Chairperson & CEO
MAHON PAUL A, EVP & GENERAL COUNSEL
Mesa Nilda, Director
DZAU VICTOR J, Director
Thompson Tommy G, Director
Tracey Kevin, Director

How to read Form 4 transaction codes